Johanna Griesbaum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Johanna Griesbaum has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alex Dulovic
NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
1 shared publication - Berit Lange
Helmholtz-Zentrum für Infektionsforschung, Braunschweig, Germany
1 shared publication - Christopher Chiu
Department of infectious disease, Imperial College London, London, UK
1 shared publication - Hanna Renk
University Children’s Hospital Tuebingen, Tuebingen, Germany
1 shared publication - Jonathan Remppis
Neuropediatrics, General Pediatrics, Diabetology, Endocrinology and Social Pediatrics, University Children's Hospital Tübingen, Tübingen, Germany.
1 shared publication - Madeleine Fandrich
NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
1 shared publication
Latest Publications
- Open Access
- 8 February 2024
- Published by Springer Nature in Infection
- Vol. 52 (2) , 597-609
Development and validation of a respiratory syncytial virus multiplex immunoassay
Purpose: Respiratory syncytial virus (RSV) is one of the leading causes of severe respiratory disease in infants and adults. While vaccines and monoclonal therapeutic antibodies either are or will shortly become available, correlates of protection remain unclear. For this purpose, we developed an RSV multiplex immunoassay that analyses antibody titers toward the post-F, Nucleoprotein, and a diverse mix of G proteins. Methods: A bead-based multiplex RSV immunoassay was developed, technically validated to standard FDA bioanalytical guidelines, and clinically validated using samples from human challenge studies. RSV antibody titers were then investigated in children aged under 2 and a population-based cohort. Results: Technical and clinical validation showed outstanding performance, while methodological developments enabled identification of the subtype of previous infections through use of the diverse G proteins for approximately 50% of samples. As a proof of concept to show the suitability of the assay in serosurveillance studies, we then evaluated titer decay and age-dependent antibody responses within population cohorts. Conclusion: Overall, the developed assay shows robust performance, is scalable, provides additional information on infection subtype, and is therefore ideally suited to be used in future population cohort studies.
- 8 February 2024
- Published by Springer Nature in Infection
- Vol. 52 (2) , 597-609
Open AccessDevelopment and validation of a respiratory syncytial virus multiplex immunoassay
Purpose: Respiratory syncytial virus (RSV) is one of the leading causes of severe respiratory disease in infants and adults. While vaccines and monoclonal therapeutic antibodies either are or will shortly become available, correlates of protection remain unclear. For this purpose, we developed an RSV multiplex immunoassay that analyses antibody titers toward the post-F, Nucleoprotein, and a diverse mix of G proteins. Methods: A bead-based multiplex RSV immunoassay was developed, technically validated to standard FDA bioanalytical guidelines, and clinically validated using samples from human challenge studies. RSV antibody titers were then investigated in children aged under 2 and a population-based cohort. Results: Technical and clinical validation showed outstanding performance, while methodological developments enabled identification of the subtype of previous infections through use of the diverse G proteins for approximately 50% of samples. As a proof of concept to show the suitability of the assay in serosurveillance studies, we then evaluated titer decay and age-dependent antibody responses within population cohorts. Conclusion: Overall, the developed assay shows robust performance, is scalable, provides additional information on infection subtype, and is therefore ideally suited to be used in future population cohort studies.